Professional Documents
Culture Documents
Journal of
Pediatric Critical Care Official Journal of IAP Intensive Care Chapter
CONTENTS
From the Editors Desk
Original Article
Intravenous Immunoglobulin use in Pediatric Intensive Care Unit of a Developing Country
Humaira Jurair; et al (Karachi, Pakistan)
Case Report
Post ECMO Cortical Microbleed with Good Neurological Outcome: A case report
Ohri A; et al (New Delhi, India)
3 rd E
N ew
ditio
BPIC n,
C Ma 2015
Publ nu
ishe al
d
Some upcoming
Basic Pediatric Intensive Care Course (BPICC)
Courses:
NCPCC 2016, Mumbai
Pedicon 2017, Bengaluru
Criticare 2017, Kochi
BPICC 2016
April 2016 Kanpur, Amritsar, lucknow, Ahmedabad…
and more
Dr Vishram Buche
Chairperson, IAP Intensive Care Chapter
M: 9823017254 • Email: vbuche@gmail.com
Dr Anil Sachdev
Chairperson, IAP Intensive Care Chapter
M: 9810098360 • Email: anilcriticare@gmail.com
Regional Conveners:
Dr Vikas Taneja (Gurgaon)
Dr Anjul Dayal (Hyderabad)
Dr Gnanam (Bengaluru)
Dr Parthsarathi Bhattacharya (Kolkotta)
Dr Vinay Joshi (Mumbai)
Founder Conveners:
Dr Praveen Khilnani Dr Rajiv Uttam Dr Krishan Chugh
Vol. 3 - No.1 January - March 2016 ii JOURNAL OF PEDIATRIC CRITICAL CARE
Contents
Editorial Board 2
Chairman Message 6
Original Article
Intravenous Immunoglobulin use in Pediatric Intensive Care Unit of a Developing 7
Country
Humaira Jurair, Amber shabir, Kashif Hussain, Qalab-e- Abbas, Anwar-ul-Haque
Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan
Latest Pearls
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) 11
Infectious disease society of America (IDSA) Guidelines for invasive candidiasis 12
Journal Scan
K Chugh
Fortis memorial hospital and research centre,Gurgaon
• Fluid Resuscitation in Septic Shock: Modified PALS guidelines post FEAST trial 14
• Oxygenation Index at Onset vs at 24 Hours in PARDS 17
• SpO2 Target in Bronchiolitis 19
• Appropriate Choice and Timing of Antibiotics not enough for Good Outcomes 22
in MDR Severe Sepsis
• Role of HFOV in PICU post OSCILLATE and OSCAR trials 24
• Low T V For Non-ARDS Also 25
Case Report
Post ECMO Cortical Microbleed with Good Neurological Outcome: A case report 28
Ohri A; et al (New Delhi, India) Post ECMO Cortical Microbleed with Good
Neurological Outcome: A case report
Ohri A, Maniya N, Singh MP, Sharma R, Chawla A, Khilnani P
BLK Superspeciality Hospital, New Delhi
Critical Thinking
PICU Quiz 65
Praveen Khilnani
BLK Superspeciality Hospital, New Delhi & Mediclinic City Hospital, Dubai
Dr Hiren Patel Dr Sunil Vaidya Dr Sachin Shah Dr Agni Shekar Dr Arun Baranwal
West Zone West Zone West Zone East Zone East Zone
Gujarat Solapur Pune Kolkotta Bihar
Executive Members
Dr Krishan Chugh
Chancellor
College of Pediatric Critical Care
Mob: +919810608580
Email: krishan.chugh@fortishealthcare.com
Dr Anil Sachdev
Course Co-ordinator
Mob: 9810098360
Email: anilcriticare@gmail.com
Dear reader
In this issue of JPCC (Jan-march 2016) we have published NCPCC2015 (National conference of Pediatric Critical
care), poster and paper abstracts revealing the research in the field of Pediatric critical care from India. This includes all
abstracts including Top three posters (1st Position: Dr Nitin Manwani 2nd Position: Dr Jamunashree B 3rd Position: Dr
Chintan Patel) and Best paper judged upon oral presentation (1st Position: Dr. Andleeb Majeed).
Original article regarding experience with immunoglobulin therapy from a developing country (Dr Humaira Jurair; et al)
is high lighted. This issue highlights Extra corporeal membrane oxygenation (ECMO) experience by Dr Ankur Ohri; et
al: A relatively new life saving technology for severe hypoxemic respiratory or cardiopulmonary failure rapidly on the
rise in this part of the world.
Latest pearls highlight the 2016 Sepsis definitions and IDSA (infectious disease society of America) guidelines for the
treatment of invasive candidiasis.
Journal scan by Dr Krishan chugh scans important evidence based publications related to fluid resuscitation in septic
shock, Oxygen saturation targets in Bronchiolitis, Current status of HFOV, Oxygenation index in PARDS, Low tidal
volume for non ARDS patients and Volume of distribution of antibiotics.
Circulation of the journal is rapidly on the rise in Asia and the middle eastern region. For on line submissions log in to
www.journalofpediatriccriticalcare.com. You can also visit the Facebook page and give feed back. Soon After getting the
journal indexed after a rigorous indexing process, it is planned for the Journal to be an on line publication.
Happy reading
Praveen Khilnani
Diplomat American Board of Pediatrics and Critical Care Medicine
Editor in Chief Journal of Pediatric Critical Care
Executive Board Member and Vice Chancellor College of Pediatric Critical Care
Director Pediatric Critical Care Services and Fellowship Program
BLK Superspeciality Hospital, New Delhi
Mediclinic City Hospital, Dubai
Dear friends,
To begin with I wish you all a happy and prosperous new year 2016. Indeed it’s a great privilege and honour to become
a Chairman of an esteemed, prestigious organisation to which I am attached since the birth of PICC. Thanks to all of you
for reposing faith on me by electing. Thanks to all my predecessors to bring PICC at it’s best level.
During this tenure, I would like to make PICC as “è-PICC “in the context of administration and academics. Already
a “Picu forum” platform is available initiated by young enthusiastic Intensivists, where difficult different cases with
management are discussed and innovative ideas are exchanged. Soon such expert advice for difficult cases would be
available on our official website if query arises.
Lot of mobile apps are developed by Dr Deopujari for PICC, are made available free for our members for education and
patients management. And, soon, there are many more apps in pipeline coming to our rescue.
Our BPICC program has become extremely popular and we wish and will make efforts that it would be conducted in all
corners of our country. Similarly “APICC” program, almost formulated and would be launched soon.
I congratulate Dr Krishan chugh for the commendable efforts for the conduction of fellowship programs under auspices
of college of Pediatric critical care in collaboration with PICC.
I congratulate Dr Praveen Khilnani for his extra ordinary efforts to make our journal at international level.
I shall encourage the zonal and regional CME in different parts of the country involving young Intensivists.
I appeal all to enroll new members and make our PICC more strong and vibrant.
I am confident with the help of all my colleague friends and senior advisers, PICC will be at it’s best level
Vishram Buche
Chairman
Pediatric Intensive Care Chapter of Indian Academy of Pediatrics Director,
NICU(level 3), Central India’s CHILD Hospital,
Research Institute, Mehadia Square, Dhantoli, Nagpur-440003,
M: 09823017254
Email:vbuche@gmail.com
ABSTRACT
Introduction: Intravenous immunoglobulin (IVIG) is pooled plasma product. Its use is progressively
increasing for several clinical indications.
Aim: We describe experience with IVIG use in Pediatric intensive care unit (PICU) of a developing
country.
Method: Retrospective database review was conducted at the PICU of Aga Khan Hospital, from January
2010 to June 2014. We report the demographic data, indications, efficacy and adverse effects related to
use of IVIG.
Results: A total of 56 patients received IVIG treatment. 58.9% (n = 33) patients were male. Twelve patients
(21.4%) were <1 year of age, 21 (37.5 %) were between 1year to 5 years and 23 (41.1%) were between
6 to 16 years old. Three most common indications were myocarditis, septic shock and severe capillary
leak syndrome. IVIG was found clinically efficacious in 42.9 % cases. Minor adverse events were noted
in 8.9% patients. These included 2 episodes of fever, 2 episodes of body rashes and 1 episode of fluid
responsive hypotension. Indications for IVIG use had an evidence category Ia / Ib in only 7.1%.
Conclusion: Use of IVIG was found safe in our PICU setting. However most of the indications were not
meeting high level of evidence.
Key words: Intravenous immunoglobulin, Pediatric intensive care unit, developing country
obtained. All children between 1 month to 16 years of episodes of fever, 2 episode of allergic body rashes
age who received IVIG for various indications during (3.6%) and 1 (1.8%) episode of hypotension. Adverse
their intensive care unit stay were included. Data events were managed by reducing infusion rate,
were collected on structured data collection sheet administration of anti-histaminic drugs, antipyretics,
regarding demographics variables like age, gender, fluid bolus and or stopping the infusion. There was no
diagnosis, indication and dose of IVIG, number mortality attributed to use of IVIG. The indications
of doses of IVIG prescribed, adverse effects and for IVIG use had an evidence category Ia / Ib in 7.1%
mortality. All the data were cross-checked manually of cases.
from medical records (physician and nursing notes)
and electronic data from the hospitals computerized Discussion
systems. Descriptive statistics were used.
IVIG has wide range of clinical application and there
In our study efficacy was defined as ability of IVIG to has been rapid expansion in its utilization for number
produced desired clinical benefit. We defined adverse of disease states and life threatening conditions.4 In
reactions for study purpose as: ICU, IVIG is usually prescribed when there is failure
Fever: temperature 38.3 C within 24 hours of IVIG of other treatment options to achieve response or lack
administration of alternative treatment options.
Allergic reactions: presence of rashes, itching, In this retrospective review we describe the use of
flushing, facial redness, respiratory difficulty or IVIG in patients admitted to our ICUs over a 3.5-
abdominal pain year period. When we sought IVIG administration
with evidence-based consensus guidelines, we found
Acute kidney injury: if there is a need of dialysis for
that our increased number of consumption is lacking
renal supportive care
high evidence based support5,7. Because of the cost,
Aseptic meningitis: clinical signs and symptoms of shortages and growing use of IVIG there have been
meningitis and cerebrospinal fluid consistent with attempts in many countries to develop guidelines
abnormal pleocytosis and no growth on culture for monitoring of and indications for the use of
Hypotension: As Per Pediatric Advanced Life IVIG.8 Published Literature search revealed that
Support (PALS) guidelines (6) IVIG use beyond the clearly established indications
• For infants from 1 month to 12 months, Systolic is happening worldwide. In adult studies, the use
Blood Pressure <70 mm Hg of IVIG for non-listed indications is approximately
• For children >1 year to 10 years, Systolic Blood 30–40%.9 In another study of IVIG use in ICU in
Pressure <70+ (2×age in years) adult population by Foster et al. only 19% of IVIG
• Beyond 10 years, hypotension is defined as an prescriptions were for appropriate indications.
Systolic Blood Pressure <90 mm Hg Actions of IVIG depend on both the dose and
on the pathogenesis of the underlying disease.3,8
Dosing and frequency of IVIG administration may
Results
differ significantly depending on the underlying
Of total 2532 PICU admission during the study period condition. Dose-ranging studies for therapeutic
56 patients (2.2%) received IVIG .Demographic and IVIG have shown that clinicians are mainly using
clinical characteristics are shown in (Table 1). Three two types of doses regimen i.e course of 400 mg/kg/
most common indications were myocarditis, septic day for 5 days or high doses of 1-2 g/kg with rapid
shock and severe capillary leak syndrome. The dosing administration over 1-2 days. High doses have many
of IVIG treatment varied, most 62.5% of patients immunomodulatory and anti-inflammatory effects.2
received only a single dose. The dose administered In our study, we used rapid course of high dose.
was 1gm/kg in 53.6% cases. It was found clinically We found administration of IVIG to be relatively safe.
efficacious in 42.9% patients. Adverse events Many of the side effects are mild, self limited and can
occurred in 8.9% patients which included: 2 (3.6%) be managed easily by premedication with analgesics
and antihistamines and adjustment of infusion rate. Table 2: Use of Intravenous Immunoglobulin by
Reported side effects to IVIG infusion in majority diagnosis and evidence category References:5,7,10,11
of studies range from 3% to 15%.2,8 Jethro Wu et al Diagnostic Categories Number (%) Evidence
report adverse events of 6.5%.9. Adverse events in category
our cohort were about 8.9%. There were no mortality Myocarditis 23 (41.0) III
attributed to use of IVIG. Septic shock 12 (21.4) III
Capillary leak syndrome 05 (8.92) III
Conclusion Encephalitis 03 (5.35) III
We found that IVIG use is safe with minimal Toxic shock syndrome 03 (5.35) III
complication rates. However the use of IVIG in our Gullain Barre syndrome 03 (5.35) Ia
patients is mostly for low evidence level category. Status Epilepticus 03(5.35) IIb
This highlights the need for monitoring and more Stevenson Johnson syndrome 02 (3.57) IIa
thoughtful prescription for those conditions for Jevunile Rheumatoid Arthritis 01(1.78) IIb
which there is recognized support in the medical with HLH
literature for IVIG’s therapeutic effectiveness. If ITP with Intracranial 01(1.78) Ia
clinical benefit are experienced by individual center Hemorrhage
following use of IVIG in condition other than those
with category I/IIa level evidence, then such finding Acknowledgment
should be published in Peer reviewed literature, so We express our warm thanks to Dr. Asad Ali for
they could influence the policy recommendation. his support and guidance in grammar and language
Table 1: Demographic and clinical characteristics of patients editing.
receiving IVIG
Characteristics Number Percentage References
Gender Male 33 58.9 1. Foster R, Suri A, Filate W, Hallett D, Meyer J, Ruijs T,
Female 23 41.1 et al. Use of intravenous immune globulin in the ICU: a
1 month - 12 months 12 21.4 retrospective review of prescribing practices and patient
Age outcomes. Transfus Med. Dec;20(6):403-8.
13 months - 59 months 21 37.5 2. Prasad AN, Chaudhary S. Intravenous immunoglobulin
5 years - 15 years 23 41.1 in pediatrics: A review. Med J Armed Forces India.
Dosage 1 gm/kg 30 53.6 Jul;70(3):277-80.
3. Jolles S, Sewell WA, Misbah SA. Clinical uses of intravenous
2 gm/kg 26 46.4 immunoglobulin. Clin Exp Immunol. 2005 Oct;142(1):1-11.
Number One dose 35 62.5 4. Hartung HP, Mouthon L, Ahmed R, Jordan S, Laupland
of doses Two doses 19 33.9 KB, Jolles S. Clinical applications of intravenous
immunoglobulins (IVIg)--beyond immunodeficiencies and
More than two doses 2 3.6 neurology. Clin Exp Immunol. 2009 Dec;158 Suppl 1:23-33.
Adverse Fever 2 3.6 5. Galal NM. Pattern of intravenous immunoglobulins (IVIG)
effects Hypotension 1 1.8 use in a pediatric intensive care facility in a resource limited
setting. Afr Health Sci. Jun;13(2):261-5.
Rashes 2 3.6 6. Kleinman ME, Chameides L, Schexnayder SM, Samson RA,
Patient Cardiac 28 50.0 Hazinski MF, Atkins DL, et al. Part 14: pediatric advanced
Categories Hematology 1 1.8 life support: 2010 American Heart Association Guidelines
for Cardiopulmonary Resuscitation and Emergency
Immunology 2 3.6
Cardiovascular Care. Circulation. Nov 2;122(18 Suppl
Infectious 15 26.8 3):S876-908.
Neurology 10 17.8 7. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M,
Bonilla FA, et al. Use of intravenous immunoglobulin in
Total No 56
human disease: a review of evidence by members of the
Primary Immunodeficiency Committee of the American
Academy of Allergy, Asthma and Immunology. J Allergy population over a 10-year period. J Paediatr Child Health.
Clin Immunol. 2006 Apr;117(4 Suppl):S525-53. Aug;49(8):629-34.
8. Ramesh S, Schwartz SA. Therapeutic uses of intravenous 10. McDaneld LM, Fields JD, Bourdette DN, Bhardwaj A.
immunoglobulin (IVIG) in children. Pediatr Rev. 1995 Immunomodulatory therapies in neurologic critical care.
Nov;16(11):403-10; quiz 10. Neurocrit Care. Feb;12(1):132-43.
9. Wu J, Lee AJ, Goh AE, Chia M, Ho C, Bugarin JL, et al. 11. Lambert M, Launay D, Hachulla E, Morell-Dubois S, Soland
Use of intravenous immunoglobulin in an Asian paediatric V, Queyrel V, et al. High-dose intravenous immunoglobulins
dramatically reverse systemic capillary leak syndrome. Crit
Care Med. 2008 Jul;36(7):2184-7.
Faculty: Dr Praveen Khilnani, Dr Kishan Chugh, Dr Nameeth Jeerath, Dr Rajiv Uttam, Dr Shipra Gulati,
Dr Rachna Sharma, Dr Kumar Ankur, Dr Sanjeev Chetry
Registration fee Rs 4000/-. (Last Date 12th April, 2016). All payments is to be made by DD/Cheque in
favour of Dr. B. L. Kapoor Memorial Hospital payable at Delhi or you can transfer online (please mail
your UTR no after online payment).
A/c Name: B L Kapur Memorial Hospital
A/c No:- 1522008700003800
RTGS/NEFT IFS Code:- PUNB0152200
Bank Address: Punjab National Bank, Rajindra place, New Delhi
Dr Praveen Khilnani
Organizing Chairperson and Course Director
A. The Third International Consensus Definitions convened by the Society of Critical Care Medicine
for Sepsis and Septic Shock (Sepsis-3) and the European Society of Intensive Care Medicine.
Mervyn Singer; Clifford S. Deutschman; Christopher Definitions and clinical criteria were generated
Warren Seymour; Manu Shankar-Hari; Djillali through meetings, Delphi processes, analysis of
Annane; Michael Bauer; Rinaldo Bellomo; electronic health record databases, and voting,
Gordon R. Bernard; Jean-Daniel Chiche; Craig M. followed by circulation to international professional
Coopersmith; Richard S. Hotchkiss; Mitchell M. societies, requesting peer review and endorsement
Levy; John C. Marshall; Greg S. Martin; Steven M. (by 31 societies listed in the Acknowledgment).
Opal; Gordon D. Rubenfeld; Tom van der Poll, ; Key Findings From Evidence Synthesis: Limitations
Jean-Louis Vincent; Derek C. Angus of previous definitions included an excessive focus
JAMA. 2016;315(8):801-810. doi:10.1001/jama. on inflammation, the misleading model that sepsis
2016.0287 follows a continuum through severe sepsis to shock,
and inadequate specificity and sensitivity of the
Abstract systemic inflammatory response syndrome (SIRS)
Importance: Definitions of sepsis and septic shock criteria. Multiple definitions and terminologies are
were last revised in 2001. Considerable advances currently in use for sepsis, septic shock, and organ
have since been made into the pathobiology dysfunction, leading to discrepancies in reported
(changes in organ function, morphology, cell incidence and observed mortality. The task force
biology, biochemistry, immunology, and circulation), concluded the term severe sepsis was redundant.
management, and epidemiology of sepsis, suggesting
the need for reexamination. Recommendations
Objective: To evaluate and, as needed, update Sepsis should be defined as life-threatening organ
definitions for sepsis and septic shock. dysfunction caused by a dysregulated host response
Process: A task force (n = 19) with expertise in sepsis to infection. For clinical operationalization, organ
pathobiology, clinical trials, and epidemiology was dysfunction can be represented by an increase
in the Sequential [Sepsis-related] Organ Failure have also reviewed and endorsed these guidelines.
Assessment (SOFA) score of 2 points or more, which Some of the updated recommendations address
is associated with an in-hospital mortality greater diagnosis, consultation with infectious disease
than 10%. Septic shock should be defined as a subset specialists, neonatal candidiasis, intravascular
of sepsis in which particularly profound circulatory, infections, intensive care unit prophylaxis, central
cellular, and metabolic abnormalities are associated nervous system involvement, and mucosal infections.
with a greater risk of mortality than with sepsis alone. Addressing concerns about the growing prevalence
Patients with septic shock can be clinically identified of antifungal resistance, the guideline also advocates
by a vasopressor requirement to maintain a mean testing for azole susceptibility in clinically relevant
arterial pressure of 65 mm Hg or greater and serum Candida isolates. “Testing for echinocandin
lactate level greater than 2 mmol/L (>18 mg/dL) in susceptibility should be considered in patients who
the absence of hypovolemia. This combination is have had prior treatment with an echinocandin and
associated with hospital mortality rates greater than among those who have infection with C. glabrata or
40%. In out-of-hospital, emergency department, or C. parapsilosis,” the guideline adds.
general hospital ward settings, adult patients with The update also recommends a step-down approach,
suspected infection can be rapidly identified as being initiating treatment with an intravenous antifungal
more likely to have poor outcomes typical of sepsis such as an echinocandin and then switching to an
if they have at least 2 of the following clinical criteria oral treatment, such as fluconazole.
that together constitute a new bedside clinical score Candidiasis should be considered in patients whose
termed quickSOFA (qSOFA): respiratory rate of 22/ condition deteriorates with no obvious cause, and
min or greater, altered mentation, or systolic blood in patients who have unexplained fever, have an
pressure of 100 mm Hg or less. elevated white blood cell count, have recently
Conclusions and Relevance These updated undergone abdominal surgery, or have a central
definitions and clinical criteria should replace venous catheter, according to the new guidelines. The
previous definitions, offer greater consistency for guidelines also recommend the removal of a catheter
epidemiologic studies and clinical trials, and facilitate as early as possible in candidemia if the catheter is
earlier recognition and more timely management of the presumed source and can be safely removed.
patients with sepsis or at risk of developing sepsis Other intravascular devices should also be removed.
Because a rapid specific diagnostic test remains
lacking, and diagnosis and treatment across strains
B. Infectious disease society of America (IDSA)
remain challenging, consultation with an infectious
Guidelines for invasive candidiasis
diseases specialist is recommended.
Clin Infect Dis. Published online December
Early action is key. “Time to appropriate therapy
16, 2015. http://cid.oxfordjournals.org/content/
in candidemia appears to have a significant impact
early/2015/12/15/cid.civ933.full. Accessed December
on the outcome of patients with this infection,” the
23, 2015.
guideline states. “A safe and effective prophylactic
strategy to prevent candidemia among high-risk
Invasive Candida infection is a major cause of
patients could be of great benefit.” In particular, in
morbidity and mortality in the healthcare environment.
intensive care units with rates of invasive candidiasis
Since the Infectious Diseases Society of America
elevated beyond the expected rate of less than 5%,
(IDSA) last published guidelines on this topic in
antifungal prophylaxis may be warranted in selected
2009, new data regarding diagnosis, prevention,
high-risk patients.
and treatment for proven or suspected invasive
Invasive candidiasis is one of the most serious
candidiasis resulted in significant modifications
nosocomial infections. “In fact, patients who get
of treatment recommendations. The American
candidemia are more likely to die than those whose
Academy of Pediatrics, the Pediatric Infectious
bloodstream infections are caused by bacteria,”
Diseases Society, and the Mycoses Study Group
Dr Pappas said in an IDSA statement. Also
according to the statement, some studies have daily should only be considered in patients
reported a mortality rate as high as 47% in affected with fluconazole-susceptible or voriconazole-
patients.The guideline notes that more than 90% of susceptible isolates (strong recommendation;
potentially life-threatening deep-tissue disease is low-quality evidence).
caused by 5 of 15 fungal pathogens: C albicans, C 6. When there is intolerance, limited availability,
glabrata, C tropicalis, C parapsilosis, and C krusei. or resistance to other antifungal agents, lipid
The new recommendations have been endorsed by formulation amphotericin B (3-5 mg/kg daily) is
the American Academy of Pediatrics, the Pediatric a reasonable alternative (strong recommendation;
Infectious Diseases Society, and the Mycoses Study high-quality evidence).
Group.Support for this guideline was provided by
IDSA. A majority of the authors have disclosed Treatment recommendations for candidemia in
financial relationships with industry outside the neutropenic patients include the following:
submitted work, including research grants, consulting 1. Initial therapy should be an echinocandin
or speaking fees, and royalties or patents. (caspofungin: loading dose 70 mg, then 50 mg
daily; micafungin: 100 mg daily; anidulafungin:
Treatment recommendations for candidemia in loading dose 200 mg, then 100 mg daily) (strong
non-neutropenic patients include the following: recommendation; moderate-quality evidence).
1. Initial therapy should be an echinocandin 2. An effective but less attractive alternative because
(caspofungin: loading dose 70 mg, then 50 mg of the potential for toxicity is lipid formulation
daily; micafungin: 100 mg daily; anidulafungin: amphotericin B, 3 to 5 mg/kg daily (strong
loading dose 200 mg, then 100 mg daily) (strong recommendation; moderate-quality evidence).
recommendation; high-quality evidence). 3. Fluconazole at a loading dose of 800 mg (12
2. For selected patients who are not critically ill mg/kg), then 400 mg (6 mg/kg) daily, is an
and are unlikely to have fluconazole-resistant alternative for patients who are not critically ill
Candida species, an acceptable alternative to an and have had no previous azole exposure (weak
echinocandin as initial therapy is fluconazole, recommendation; low-quality evidence).
intravenous or oral, 800-mg (12 mg/kg) loading Infections resulting from C krusei should be
dose, then 400 mg (6 mg/kg) daily (strong treated with an echinocandin, lipid formulation
recommendation; high-quality evidence). amphotericin B, or voriconazole (strong
3. All bloodstream and other clinically relevant recommendation; low-quality evidence).
Candida isolates should be tested for azole For candidemia without metastatic complications,
susceptibility, and possibly for echinocandin recommended minimum duration of therapy is
susceptibility in patients previously treated with 2 weeks after documented clearance of Candida
an echinocandin or infected with C glabrata or C from the bloodstream, provided neutropenia and
parapsilosis (strong recommendation; low-quality candidemia-related symptoms have resolved
evidence). (strong recommendation; low-quality evidence).
4. Patients who are clinically stable, have isolates Dilated funduscopic examinations should be
susceptible to fluconazole, and have negative performed within the first week after recovery
results on repeated blood cultures after starting from neutropenia, because ophthalmologic
antifungal therapy should transition from an findings of choroidal and vitreal infection are
echinocandin to fluconazole, usually within 5 to minimal until recovery from neutropenia (strong
7 days (strong recommendation; moderate-quality recommendation; low-quality evidence).
evidence) or from amphotericin B to fluconazole Sources of candidiasis other than a central venous
after 5 to 7 days (strong recommendation; high- catheter predominate in the neutropenic patient,
quality evidence). so catheter removal should be considered on an
5. For C glabrata infection, transition to higher- individual basis (strong recommendation; low-
dose fluconazole 800 mg (12 mg/kg) daily or quality evidence).
voriconazole 200 to 300 (3-4 mg/kg) twice
temperature gradient, weak radial pulse volume, or be harmful (Class IIb, LOE B-R). Providers should
severe tachycardia. In this study, administration of 20 reassess the patient after every fluid bolus (Class I,
mL/kg or 40 mL/kg in the first hour was associated LOE C-EO).
with decreased survival compared with the use of
maintenance fluids alone. Therefore, it appears that Crystalloid vs. Noncrystalloid
in this specific patient population, where critical
The use of noncrystalloid fluid was compared with
care resources including inotropic and mechanical
crystalloid fluid for the same diseases and outcomes
ventilator support were limited, bolus fluid therapy
listed in the preceding paragraphs2-8. Evidence is
resulted in higher mortality. This trial included large
summarized in (Figure 2). In most scenarios, there
number of children who were malnourished and
was no benefit to noncrystalloids over crystalloids. In
many had malaria rather than bacterial sepsis.
patients with Dengue shock, a benefit was conferred
in using noncrystalloid compared with crystalloid
2015 Recommendations—New fluid for the outcome of time to resolution of shock7.
Administration of an initial fluid bolus of 20 mL/
kg to infants and children with shock is reasonable, 2015 Recommendations—New
including those with conditions such as severe sepsis
Either isotonic crystalloids or colloids can be
(Class IIa, LOE C-LD), severe malaria and Dengue
effective as the initial fluid choice for resuscitation
(Class IIb, LOE B-R).
(Class IIa, LOE B-R).
When caring for children with severe febrile illness
Thus this update regarding intravenous fluid
(such as those included in the FEAST trial) in
resuscitation in infants and children in septic shock in
settings with limited access to critical care resources
all settings addressed 2 specific therapeutic elements:
(ie, mechanical ventilation and inotropic support),
(1) Withholding the use of bolus fluids was compared
administration of bolus intravenous fluids should
with the use of bolus fluids, and (2) noncrystalloid
be undertaken with extreme caution because it may
was compared with crystalloid fluids in various types
Studies Survival to Need for Need for Mechanical Time to Total IV Hospital
Hospital Other Rescue Ventilation or Resolution Fluids Duration of
Discharge Treatment Fluid Vasopressor of Shock Stay
Severe sepsis/ Upadhyay No Benefit No Benefit No Studies No Benefit No Benefit No Studies No Studies
septic shock 2005 Available Available Available
Severe malaria Maitland No Studies No Benefit No Studies No Studies No Benefit No Studies No Studies
2003; Available Available Available Available Available
Maitland
2005
Dengue shock Cifra 2003; No Benefit No Benefit No Benefit No Studies Benefit No Benefit No Benefit
Dung 1999; Available
Ngo 2001;
Wills 2005
Severe febrile Maitland No Benefit No Benefit No Benefit No Studies No Benefit No Benefit No Studies
illness with some 2011 Available Available
but not all signs
of shock
Figure 2: Evidence for the use of noncrystalloid intravenous fluid resuscitation, compared with cystalloid, by presenting illness and
outcome. Benefit indicates that studies show a benefit to the use of noncrystalliod intravenous fluid resuscitation compared with
crystalloid, and No Benefit indicates that there is no benefit to the use of noncrystalloid intravenous fluid resuscitation compared with
crystalloid. No studies available indicate no studies are available for a particular illness/ outcome combination.
PIP (cm H2O) 30 (25, 35) 27 (24, 32) Initial PaO2/ FiO2 0.580 (0.480-0.680) 0.116
Mean airway 16 (14, 18) 15 (14, 19) 24-hr PaO2/ FiO2 0.684 (0.594- 0.774) <0.001
pressure (cm H2O) Worst PaO2/ FiO2 in first
0.691 (0.611-0.771) <0.001
Exhaled VT (mL/ kg 7.5 (6.7, 8.3) 7.3 (6.5, 8.1) 24hr
actual body weight) Initial OI 0.581 (0.472-0.689) 0.114
Exclusion criteria were 1) respiratory failure from 24-hr OI 0.661 (0.573-0.749) 0.002
cardic failure (determined by echocardiography) or Worst OI in the first 24 hr 0.661 (0.578-0.743) 0.002
fluid overload, 2) exacerbation of underlying chronic
In none of the 3 major diagnosis guidelines [AECC2,
respiratory disease, 3) chronic ventilator dependence,
Berlin3, PARDS consensus guidelines4] has the
4) mixing cyanotic heart disease, 5) mechanical
timing of oxygenation indices, PaO2/ FiO2 ratio or OI
ventilation for more than 7 days before PaO2 / FiO2
been defined. However, each one of these definition
up to 300, and 6) ARDS established outside of the
has contributed significantly to better understanding
CHOP PICU.
and bedside management of ADRS in children.
Decelerating flow (PC or PRVC) was used for
This study was initiated in 2011 before the publication
conventional ventilation. Twenty four hours after
of PALICC or Berlin study. However, all patients met
meeting ARDS criteria, 61 patients transitioned to
the Berlin definition criteria, as all of them were on
alternative modes (33 HFPV, 24 HFOV and four
PEEP of more than 5cm H2O. Thus, it is relevant
Data are median (IQR); n or estimate of difference (95% CI), unless otherwise stated.
* Median difference is standard–modified (<0 indicates benefit to standard practice).
† HR is standard /modified (<1 indicates benefit to standard practice).
‡ Equivalence defined as plus or minus 2 days.
§ Equivalence defined as plus or minus 4 h.
¶ Equivalence defined as plus or minus 2 days.
must be emphasised that more severe cases requiring the number of admissions to the wards in infants
admission to High Dependency Unit or Pediatric suffering from bronchiolitis besides cutting down the
Intensive Care Unit were not included in this study. duration of study and hence the costs. In an editorial
Such children should still be treated by standard comment3 on this BIDS study questions have been
interventions including oxygen administration. raised about the use of supplemental oxygen in
The AAP guideline1 does not apply to children other acute hypoxic states, such as exacerbations of
with immunodeficiencies, including those with asthma and community- acquired pneumonia. The
HIV infection or recipients of solid organ or decision about acceptable oxygen saturations for
hematopoietic stem cell transplants. Children these disorders is also based on expert opinion and
with underlying respiratory illnesses, such as becomes a matter of clinical judgment, availability of
recurrent wheezing, chronic neonatal lung disease health- care resources, and cost implications.
(also known as bronchopulmonary dysplasia),
neuromuscular disease, or cystic fibrosis and those References
with hemodynamically significant congenital 1. Ralston SL, Lieberthal AS, Meissner HC et al. Clinical
heart disease are excluded from the sections on Practice Guideline: The Diagnosis, Management, and
management. The AAP guideline does not address Prevention of Bronchiolitis. Pediatrics 2014; 134(5):e1474–
long-term sequelae of bronchiolitis, such as recurrent e1502
2. Cinningham S, Rodriguez A, Adams T et al. for the
wheezing or risk of asthma, which is a field with a
Bronchiolitis of Infancy Discharge Study (BIDS) group:
large and distinct literature. Similarly, results of this Oxygen saturation targets in infants with bronchiolitis
Cunningham study2 are also not applicable to the (BIDS): a double-blind, randomized, equivalence trail.
above specified groups. Lancet 2015; 386: 1041-1048
This study has the potential for bringing down 3. Wainwright CE, Kapur N. Oxygen saturation targets in
infants with bronchiolitis. Lancet 2015; 386: 1016-1018
calamity associated with septic shock. However, antibiotic to a patient with leaky capillaries will result
appropriate therapy is still crucial, as suggested by the in a lower concentration of the antibiotic in the serum,
low overall mortality in this cohort (13.1%) compared particularly a lower maximal concentration (Cmax).
to studies with varying levels of appropriate empiric Studies have demonstrated an increased organ blood
antimicrobial therapy. flow early in sepsis2. Clinically this means in the
presence of normal renal function, an increased
Limitations of the study are: organ, namely renal blood flow, will translate into
an increased glomerular filtration rate and hence
1. Retrospective,
an increased creatinine clearance. This clinical
2. Single- center study,
phenomenon has now been termed augmented renal
3. Did not study outcomes in patients with Gram-
clearance (ARC). ARC will result in increased
positive infections or non-Enterobacteriaceae
clearance of all renally eliminated drugs. In four
Gram-negative infections. It is possible that there
multidisciplinary ICUs across the world, ARC
would be different results in these populations,
has now been documented in more than 60% of
4. Antimicrobial minimum inhibitory concentration
patient admitted with a “normal” serum creatinine
(MIC) data to determine if the administered
concentration3. This practical implication of ARC with
antibiotics were therapeutic at a given MIC was
standard dosing of antibiotics with renal clearances
not taken into account.
(ß- lactams, aminoglycosides, and glycopeptides) will
5. Assessment of differential outcomes based on
be that the resultant serum antibiotic concentration
specific pathogens could not be assessed due to
will be low, often subtherapeutic4.
the low frequency of infection with pathogens
other than E. coli and K. pneumoniae. On the basis of above principles it can be concluded
that in patients with septic shock we should consider
• Loading doses for increased Vd and
Comments
• Increased frequency of administration to
Thus this study shows that using the correct antibiotic, compensate for ARC.
that is, that appropriate for organism susceptibility,
plus correct timings of administration, is not enough These facts also provide a strong case for therapeutic
to ensure a good outcome. drug monitoring for not only preventing toxicity but
Study emphasises that factors beyond the correct also improving efficacy.
choice of antibiotic should be considered when
treating patients with sepsis, particularly those References
requiring intensive care supports. Increased 1. Burnham JP, Lane MA, Kollef MH. Impact of Sepsis
volume of distribution (Vd) of hydrophilic drugs Classification and Multidrug-Resistance Status on Outcome
Among Patients Treated With Appropriate Therapy. Crit Care
and hyperdynamic circulatory system associated
Med 2015; 43:1580-1586
with increased renal blood flow and elevated drug 2. Di Giantomasso D, May CN, Bellomo R.Vital organ blood
clearance are knownto alter antibiotic PK exposure flow during hyperdynamic sepsis.Chest 2003; 124: 1053-
and reduce antibiotic serum concentration. 1059
Patients with severe infections are often given large 3. Udy AA, Baptista JP, Lim NL, et al. augmented renal
clearance in the ICU : Results of a multicentre observational
amounts of fluids in the initial resuscitative phase study of renal function in critically ill patients with normal
of sepsis. Leaky capillaries and hypoproteinemia plasma creatinine concentrations. Crit Care Med 2014; 42:
predispose these patients to swelling with 520-527
extravascular fluid extravasation., This increase 4. Lipman J, Roberts J. Does appropriate antibiotic therapy
mean only adequate spectrum and timing. Crit Care Med
will produce a markedly large increase in Vd of
2015; 43: 1773-1774
hydrophilic antibiotics. Due to this increased Vd,
administering the same dose of an hydrophilic
Despite limited clinical trial data1,2, HFOV is being which may represent an attempt to provide enhanced
used in children as a rescue mode of ventilation when lung protection with HFOV.
conventional lung protective ventilatory modalities The strengths of this study are that authors have
have failed3 . complete HFOV data on all patients included in the
It is believed that HFOV provides lung protective analysis. Furthermore, they have included both small
ventilation with lower peak-to-trough pressure and large centers from North America and Western
amplitudes while simultaneously preventing alveolar Europe and therefore believe that their data provide
collapse. a robust description of current practice. The major
A meta- analysis published in 2010 concluded that weakness is that this is a retrospective, questionnaire
HFOV may decrease mortality, in adults as well as study. Comparison data and criteria for changes from
children4. However, two recent trials of HFOV in CMV to HFOV are not available. They also did not
adults (OSCAR trial5 and OSCILLATE6 trial) showed collect hemodynamic data. In addition, there are more
no benefit. Indeed, OSCILLATE trial from Canada cases from North America than from Europe. This
showed higher mortality in HFOV group compared may potentially skew the study to better represent
to CMV group. North American practices.
In PICUs across the world HFOV continues to
be used, albeit somewhat differently. Unlike the References
OSCILLATE study group where HFOV was used in 1. Arnold JH, Hanson JH, Toro-Figuero LO, et al: Prospective,
early ARDS the general practice in PICUs is to use randomized comparison of high-frequency oscillatory
HFOV as a rescue therapy when the MAP and OI are ventilation and conventional mechanical ventilation in
very high. pediatric respiratory failure. Crit Care Med 1994; 22:1530–
1539
In a retrospective study reported recently7 three
2. Samransamruajkit R, Prapphal N, Deelodegenavong J, et al:
North American and four European centres were Plasma soluble intercellular adhesion molecule-1 (sICAM-1)
surveyed regarding HFOV practices. A total of 328 in pediatric ARDS during high frequency oscillatory
case report forms of children who were on HFOV in ventilation: A predictor of mortality. Asian Pac J Allergy
2009 and 2010 were studied. Results of this study are Immunol 2005; 23:181–188
3. Arnold JH, Anas NG, Luckett P, et al: High-frequency
discussed below. oscillatory ventilation in pediatric respiratory failure: A
In the Rettig paediatric study7 representative groups, multicenter experience. Crit Care Med 2000; 28:3913–3919
greater than 70% of patients had an OI greater than 4. Sud S, Sud M, Friedrich JO, et al: High frequency oscillation
16 preceding initiation of HFOV, with the majority in patients with acute lung injury and acute respiratory
distress syndrome (ARDS): Systematic review and meta-
(> 60%) having an OI greater than 24. This implies
analysis. BMJ 2010; 340:c2327
that in current paediatric practice, HFOV is still being 5. Young D, Lamb SE, Shah S, et al; OSCAR Study Group:
used as a rescue strategy and not as a primary mode High-frequency oscillation for acute respiratory distress
of ventilatory support. Therefore, the OSCILLATE syndrome. N Engl J Med 2013; 368:806–813
data, which focuses on primary application of HFOV 6. Ferguson ND, Cook DJ, Guyatt GH, et al; OSCILLATE
Trial Investigators; Canadian Critical Care Trials Group:
in adults, may not be applicable to current paediatric High-frequency oscillation in early acute respiratory distress
practice. syndrome. N Engl J Med 2013; 368:795–805
Data of this study demonstrate that canters in North 7. Rettig JS, Smallwood CD, Walsh BK, et al. High-Frequency
America and Western Europe are using higher Hertz, Oscillatory Ventilation in Pediatric Acute Lung Injury: A
Multicenter International Experience. Crit Care Med2015;
higher delta P strategies compared to a decade back,
XX:00–00)
Table: comparison of pulmonary complications rate and in-hospital mortality in the three groups
Variables Less than or Greater than 7 and less Greater than Adjusted P Adjusted Or P
equal to 7ml/ than 10 mL/kg PBW or equal to 10 OR(Low Vs (Intermediary VS
kg PBW mL//kg PBW High)(95%CI) High ) (95%CI)
Pulmonary 166(23) 21(28) 220(31) 0.72(0.52-0.98) 0.042 0.93(0.69-1.24) 0.635
complications
Acute 86(12) 121(16) 163(23) 0.48(0.32-0.71) <0.01 0.73(0.52-1.03) 0.074
respiratory
distress
syndrome
Pneumonia 122(17) 158(21) 106(15) 1.47(0.89-2.21) 0.093 1.27(0.86-1.86) 0.223
In – hospital 245(34) 279(37) 270(38) 0.82(0.65-1.02) 0.081 0.90(0.73-1.10) 0.319
mortality
of ventilation , patients were assigned to a “ low tidal have been differential misclassification which may
volume group ”(tidal volumes <_7mL/kg predicted vary among the RCTs and observational studies.
body weight) an “intermediate tidal volumes group Furthermore, patients from studies were not equally
”(>7 and <10mL/kg predicted body weight ), and a distributed between the three tidal volumes groups.
“ high tidal volume group ”(_> 10mL/kg predicted Fourth, despite the fact that author included patients
body weight and the groups compared. without ARDS in the cohort, they found a low PaO2/
FIO2 in this group of patients also. However, it
Strenghts should be emphasized that the diagnosis of ARDS
is based on several criteria and not only on PaO2/
The major strengths of the present analysis are the
FIO2. Indeed, patients could have low PaO2/ FIO2
large sample size, the appropriate statistical analyses
but no infiltrates in the chest radiographs or a
performed, and the inclusion of several patients
pulmonary edema may have been fully explained by
from diverse study types from different parts of the
cardiogenic problems. Fifth, despite the fact that the
world. Study estimated the mortality attributable
calculation of predicted body weight was the same
to pulmonary complications and its relationship
in all studies, no study described how the height was
with tidal volume used the first days of mechanical
assessed. Finally, it is important to keep in mind that
ventilation.
93% patients included in the analysis came from
observational studies, which may have introduced
Limitations bias due to a more heterogeneous population.
Although this study analysis shows a clear statistical Although comparison between the low and
difference between use of low and high tidal intermediate tidal volume groups did not achieve
volumes with respect to occurrence of pulmonary statistical significance, the 8% lower risk of
complication, the difference found between low and complications in the low tidal volume group appears
intermediate tidal volumes did not reach statistical to support a dose –response relationship between
significance. Second, there is no information about tidal volume and the pulmonary complications. By
some important risk factors that could also contribute performing an individual patient data meta –analysis,
to development of pulmonary complications, the authors were able to standardize the analysis of
including fluid overload, transfusion of blood data obtained from multiple studies, which is an
products etc. Third, since the diagnosis of ARDS important strength of this study.
and pneumonia was based on subjective criteria,
misclassifications of patients might underestimate Final Answer
the observed effect, but this factor should be equally
Well- powered RCT comparing ventilation with lower
affected the different groups. However, there could
tidal volumes with traditionally sized tidal volume in
non-ARDS patient should provide the answer. Two tidal volume of 6mL/kg PBW and other patients
randomized controlled trials are currently enrolling ,excepting those with contraindications to lower tidal
patients and may provide additional evidence volumes, receive tidal volumes of less than 8 mL/kg
to inform the most appropriate tidal volume for PBW.
critically ill patients without ARDS. The ‘Preventive
strategies in acute respiratory distress syndrome References
trial’ is a multicentre randomized controlled trial 1. Serpa Neto A, Cadoso SO, Manetta et al. Association
comparing low tidal volume ventilation (4-6mL/kg betweenuse of lung protective ventilation with lower tidal
PBW) with high tidal volume ventilation (8-10mL/ volumes and clinical outcomesamong patients without acute
kg PBW) in patients at a risk for ARDS3. The primary respiratory distress syndrome: A meta analysis. JAMA 2012;
308: 1651-1659
outcome of this study is the development of ARDS
2. Serpa Neto A, Simonis FD, Barba CSV et al. Lung protective
during the first 7 days of mechanical ventilation. The ventilation with low tidal volumes and the occurrence
‘Protective Ventilation in patients without ARDS at of pulmonary complications in patients without acute
start of ventilation trial’ is a multicenter randomized respiratory distress syndrome: A systematic review and
controlled trial comparing low tidal volume individual patient data analysis. Crit Care Med 2015; 43:
2155-2163
ventilation (4-6mL/kg PBW ) with high tidal volume 3. Tauli CP Preventive Strategies in Acute Respiratory Distress
ventilation (8-10mL/kg PBW) in patients without Syndrome (ARDS) (EPALI). 2014 Available at: https://
ARDS who are anticipated to require mechanical clinicaltrials.gov/ct2/show/NCT02070666. Accessed June
ventilation for more than 24 hours4.The primary 12, 2015
4. Simonis FD, Binnekade JM, Braber A, et al. PReVENT—
endpoint is the number of ventilator –free days and
Protective ventilation in patients without ARDS at start of
alive at a day 28. These studies are estimated to ventilation: Study protocol for a randomized controlled trial.
complete enrolment in 2016 and 2017, respectively. Trials. 2015;16:226
Taking this Serpa Neto study and the other current 5. Ogbu OC, Martin GS, Murphy DJ. A few millilitres of
evidence into consideration, Ogbu et al5 recommend prevention: Lung protective ventilation decreases pulmonary
complications. Crit Care Med 2015; 43: 2263-2064
that mechanically ventilated ARDS patients receive
ABSTRACT
Extracorporeal membrane oxygenation (ECMO) is used to support patients of all ages with acutesevere
respiratory failure which does not respond to conventional treatments. Over the years its use in older
children and adults is increasing.
We hereby report a case of 3 and a half year old girl child with primary acute respiratory distress syndrome.
She did not respond to conventional ventilation and rescue therapy underwent Venovenous (V-V) ECMO.
Post ECMO she had poor neurological status with cortical microbleeds in MRI, however she had complete
neurological recovery in due course of time.
Neurological injuries are feared complications of ECMO that result in increased patient morbidity and risk
of death. The incidence of neurological complications related to ECMO in neonates and children has been
reported to be between 9.9% and 17.3%.
Key words: Outcome, Pediatrics, ECMO, neurological complications, cerebral, microbleed
Case History
A 3 year old female child was admitted with the
chief complaints of fever with signs and symptoms
of upper respiratory infectionfor 4 days, difficulty in
breathing for 2 days. Child worsened on the medical Figure 1: Chest X ray just before ECMO initiation
and adequate chest rise with PEEP of 8 cm of H2O on mechanical ventilation even after coming off
with titration she continued to have high ventilator ECMO (chest x ray shown in Figure 3 and Figure
requirement (PIP- 35, fio2 100%, PEEP 14) 4) . Child was successfully weaned from ECMO
after 10 days of initiation. Mechanical ventilator
Chest skiagram showed bilateral fluffy shadows support was continued for another 4 days.Child had
more prominent on the left side (Figure 1). Other poor neurological status. She had hypotonia, no
Investigations were normal counts, with normal appropriate response, no eye contact, no cry or smile,
CRP, with sterile cultures. menace sign negative but the pupils were normal size
Child remained stable on conventional ventilation and were reacting normally to light. Child also had
in initial 24 hrs and Fio2 was titrated to 50%with a temporary autism evident clinically. MRI brain was
PEEP of 12 and plateau pressures of 28, MAP-18. done which revealed multiple cortical micro bleeds in
Pao2/Fio2 ratio was 150. bilateral internal capsule, in the corpus callosum ,in
On day 2 child deteriorated ,became hemodynamically bilateral supra and infra tentorial brain parenchyma
unstable, Pao2/Fio2 ratio- 85. Chest skiagram predominantly involving the white matter.
showed further worsening (Figure 2). Child showed
no response to rescue therapy including recruitment
maneuvers and prone positioning.
Tracheal decannulation was done on day 28 of investigations are limited to cranial ultrasound and
admission. Child was discharged home on day 45 Doppler at the bed side due to transport difficulties
after admission. On subsequent follow up child had in transporting the ECMO patient to CTscanner
complete neurological recovery. or MRI, unless a portable CT scanner is available.
Recently portable CT scanner has become available
Discussion in few countries.
ECMO is now widely used in pediatric patient
population if they don’t respond to conventional Conclusion
ventilation. Various studies have shown that the overall Neurological sequalae of ECMO can occur but
survival rate of patients on ECMO is 56%. Among close followup of neurological status while on
pediatric patients treated with ECMO mortality varies ECMO is important to detect these complications
by pulmonary diagnosis, underlying condition, other early. Management for those complications remains
non-pulmonary organ dysfunction as well as patient supportive.
age, but has remained relatively unchanged overall
(56%) over the past several decades. Additional risk References
factors associated with death include prolonged use of 1. David S Liebeskind, Nerses Sanossian, Monica L Sapo et
mechanical ventilation (>2 wk) prior to ECMO, use al:Cerebral microbleeds after use of extracorporeal membrane
of VA ECMO, older patient age, prolonged ECMO oxygenation in children: J Neuroimaging Jan 2013
support as well as complications during ECMO. 2. Deena M Nasr, Alejandro A Rabinstein: Neurological
complications of extracorporeal membrane oxygenation: J
Neurological complications occur in the range of 9.7%- Clinical neurology 2015
17.3%. Cerebral microbleeds (CMB) may be seen in 3. Zabrocki LA, Brogan TV, Statler KD, et al: Extracorporeal
children receiving ECMO. The etiology is unknown membrane oxygenation for pediatric respiratory failure:
with many studies suggesting micro air embolism as Survival and predictors of mortality. Crit Care Med 2011; 39
the possible culprit, other causes may be microvascular 4. Neurological complications of extracorporeal membrane
trauma, hypoperfusion or simply focal hemorrhages. In oxygenation in children. Shawn L Harvey-Jumper, Gail M
Annich, Andrea R Yancon et al:J Neurosurg pediatric 7: 338-
a 12 patient case review the CMB were most commonly 344, 2011
situated at the border zone within the right internal 5. Nobuyunki N, Ichiba S, Tsukahara K et al: Acute respiratory
carotid artery distribution. This spatial distribution distress syndrome in a child with severe epileptic disorder
potentially implicates embolic phenomena via the treated successfully by ECMO, a case report:BMC pediatric
recipient site of venoarterial bypass into the right 2015 April1;15:20
common carotid artery used in all their cases. 6. Orr RA, Dalton HJ. Extracorporeal membrane
oxygenation and right sided brain lesions. Pediatrics.
CMB may not lead to any change in ECMO techniques 1989;83:635-636[PubMed]
for cardiopulmonary or respiratory support but such 7. Taylor GA, Fitz CR, Miller MK et al. Intracranial
injuries may impair cognitive function and may alter abnormalities in infants treated with extracorporeal
the long term outcome of the patient. membrane oxygenation: imaging with US and CT, Radiology,
In our case child had multiple cerebral micro bleeds 1987;165:[PubMed 3317499]
but no other changes in the MRI to suggest hypoxia 8. Lago P, Rebsamen S, Clancy RR, et al. MRI, MRA and
neurodevelopmental outcome following neonatal ECMO.
or ischemia. The final neurological outcome was Pediatric Neurology, 1995;12:294-304[PubMed7546003]
good and child had complete neurological recovery. 9. Mendoza JC, Shearer LL, Cook LN, Lateralization
ECMO provides critical life support for infants and of brainlesions following extracorporeal membrane
children with cardiac and respiratory failure, but oxygenation. Pediatric, 1991;88[PubMed1945603]
neurological complications are common and major 10. Schumaker RE, Barks JD, Johnston MV, et al. Right-sided brain
intraparenchymal cerebral bleeds have been described brain lesions in infants following extracorporeal membrane
oxygenation. Pediatrics. 1988;82:[PubMed 3399288]
as the end point for ECMO continuation. While on 11. Wiznitzer M, Masaryk TJ, Lewin J, et al. Parenchymal and
ECMO it is recommended to do close neurological vascular magnetic resonance imaging of the brain after
followup regarding sensorium, pupillary size and extracorporeal membrane oxygenation. Am J Dis Child.
reaction, seizures and any reduction in muscle 1990; 144[PubMed 2244613]
tone and portable EEG. Unfortunately radiological
Conclusions: Respiratory-muscle weakness and upper-limb Methodology: In this prospective observational study from
power <3/5 at admission independently predicted the need of October 2013 to September 2014, 302 children admitted to the
MV for > 2 weeks at admission and upper limb power ≤ 2/5 alone PICU were screened for AKI, defined according to the AKI
reliably predicted for need of MV for > 4weeks. Network criteria. The patients with AKI were followed-up
until discharge/death. Their clinical and biochemical data were
recorded.
A Prospective Study of Serum Lactate Results: The incidence of AKI among 302 patients screened
Clearance Levels as the Predictor of was 12.6% (38). Most common diagnosis at admission were
Outcome in Pediatric Septic Shock neurological diseases (19.2%), followed by pneumonia (17.5%),
during the First 24 Hours in PICU infectious diseases (9.6%) and reactive airway disease (9.27%).
Inotropes were used in 52.6% (20) and diuretics in 23% (9) of
Darshak Makadia, Deepa Desai, Jignesh Patel, children with AKI. 13.5% (5) required renal replacement. 20
Jigesh Vaidya, Nirmal Choraria children (52.6%) suffered mortality during the hospital stay.17
cases were discharged with complete reversal of AKI and
Background: Early recognition and aggressive management one case with Hemolytic uremic syndrome was discharged as
has crucial role in the treatment of pediatric septic shock. The chronic kidney disease. On multivariate analysis there was 100%
present study was undertaken to determine the role of early mortality in children requiring mechanical ventilation and renal
lactate clearance in survival of PICU patients with severe sepsis. replacement therapy.
Results: We enrolled 86 children with a median age of 30 Conclusion: Administration of fluid bolus over 15-20 minutes
months. The incidence of VAP according to CDC criteria was is associated with lesser need for mechanical ventilation and/or
38.4%. Acinetobacter was the most frequently isolated organism impaired oxygenation in the initial hours of fluid resuscitation in
(47%) followed by Pseudomonas (28%) and Klebsiella (15%). children with septic shock.
Risk factors for VAP on bivariate analysis were use of proton Key words: Fluid bolus; septic shock; duration of bolus;
pump inhibitor (PPI), enteral feeding and re-intubation. On mortality; oxygenation index; mechanical ventilation
multivariate analysis, use of PPI (8.47: 1.19 to 60.33; p=0.03)
Objective: To study the utility of lactate clearance as a predictor Discussion: The incidence of empty sella syndrome varies
of mortality in children with septic shock 8-35% in the general population and 1.2% in children. However
high incidence up to 68% has been described in children with
Methods: Lactate was measured at admission and on days 2 and known endocrinopathy. Clinical features include hypogonadism,
3 in children aged 30 days - 18 years admitted to the PICU with Growth hormonedeficiency, and multiple pituitary hormone
septic shock. Demographic, clinical and laboratory data were deficiency. Gadolinium enhanced MRI pituitary gland is the
collected. Lactate clearance was defined as (admission lactate- investigation of choice.Primary ESS is treated with hormonal
current lactate) x 100 /admission lactate. supplementation. In secondary ESS, treatment depends upon
Results: Twenty five children were included (median age 28.5 etiology.
[14.25- 66.75] months, 36% female, median PRISM III score Conclusion: The rare causes like ESSshould be considered in
15.5[10.25-22.5]). Median lactate at admission, day-2 and day- children presenting with failure to thrive because early initiation
3 were 2.6 [2.0-3.5], 1.8 [1.2-2.75] and 1.7 [1.2-2.8] mmol/L of GH treatment gives good results.
respectively. Four children had a rise in lactate by day-2, while
7 children had a rise by day-3. A day-2 lactate clearance of
-25% (rise by 25%) predicted mortality with a sensitivity of [Award Poster: Third Position]
100% and specificity of 50% (area under the receiver operating Comparison of External Jugular Venous
characteristics curve [AUROC] 0.77). A day-3 lactate clearance
of -30% (rise by 30%) predicted mortality with a sensitivity of
access to Internal Jugular Venous
93.3% and specificity of 83.3% (AUROC= 0.91). Admission access in Pediatric septic shock: An
lactate correlated poorly with PRISM III score (r= 0.15). observational, prospective study
Discussion: Few similar Indian studies in children have shown Chintan Patel, Kushal Shah, Utkarsh Pandya,
lactate clearance to be a good indicator of mortality. Significance Krutika Tandon*
of a negative lactate clearance has not been reported though it is *Professor in Pediatrics & PICU Incharge, Department of
assumed that the associated outcome would be poor. Pediatrics, P S Medical College, Karamsad-388325,
Conclusion: An initial rise in lactate may not affect outcomes. Dist. Anand (Gujarat)
*M: 9879531972; Email: krutikart@charutarhealth.org
Lactate clearance by 72 hours of shock may be a good predictor
of mortality in children with septic shock. Background: Intravenous lines are lifelines for patients with
Type of study: Prospective observational study. shock. Central venous access is preferred but not possible
always. So we undertook this study of comparison of External
Jugular Venous(EJV) access to Internal Jugular Venous(IJV)
[Award Poster: Second Position] access for its efficacy, ease of procedure, complications and cost
Empty Sella Syndrome Resulting into effectiveness.
Short Stature in Two Siblings - A case Methods: A Prospective, Observational study from January
report with review of literature 2014 to June 2015 at PICU. Seventy pediatric patients with
Jamunashree B*, Seema Sharma, Milap Sharma shock were enrolled. Parents were explained about both EJV
Department of Pediatrics, Dr Rajendra Prasad Government and IJV routes. Depending on their affordability and consent one
Medical College, Tanda, Kangra, H.P. route was chosen. Required details were noted and descriptive
*Email: drjamuna11@gmail.com analysis was done as per objectives.
Results & Discussion: EJV and IJV had 50 and 16 subjects
Abstract: Empty sella syndrome (ESS) is the herniation of the respectively. Mean duration of reaching shock free status was
subarachnoid space into the sella through the sellar diaphragm 69.2 hours in EJV group versus 53.33 hours of IJV group.
with some degree of flattening of pituitary gland. Primary ESS Mean improvement in base deficit at the end of 24 hours as 4.3
occurs when a hole in diaphragmatic sella covering the pituitary and 6.6 in EJV & IJV groups respectively. Successful hospital
allows fluid in, which presses on pituitary. Secondary empty sella discharge was 36% and 37.5% of patients of EJV & IJV groups
syndrome occurs when the pituitary glandis injured secondary respectively. No life threatening complications in any group and
to surgery, tumour or radiation.We present two siblings with local site problems were similar in both groups. Overall attempts
Conclusion: cases had prolonged duration of hospital stay with Introduction: Familial hypercholesterolemia (FH) is a form
increased morbidity and mortality as compared to controls. of primary hyperlipoproteinemia, is an autosomal dominant
disorder, characterized by an increase in serum LDL cholesterol
A Study to Predict Respiratory Distress concentrations, presence of xanthomas and premature
atherosclerosis.In that the individuals with two mutant LDL
Syndrome using Single Step Gastric receptor alleles (FH Homozygotes) are much more affected
Aspirate Shake Test than those with one mutant allele (FH Heterozygotes). FH in
Shikha Verma*, R S Jaswal Homozygous state is rare and occurs in approximately1 in 1
Department of Pediatrics, million persons. These patients are at a high risk of developing
Dr. R. P. Govt. Medical College, Kangra (Tanda), H.P. coronary heart disease and sudden death, unless the condition is
*Email: shikha351@ymail.com recognized and treated promptly.
Case Report: Two siblings10 years old female and 8 years
Introduction: Respiratory distress syndrome (RDS) is the
old male, born out of non consanguineous marriage with
major cause of morbidity and mortality in preterm neonates.
history of xanthomatous lesions for 3 and 2years, respectively.
In India, RDS occurs in 200 000 infants/year with mortality
Physical examination showed subcutaneous yellow nodules
from RDS at 40%-60%. Lack of pulmonary surfactant leads
over the knuckles, elbows, of size up to 2 cm, suggestive of
to progressive atelectasis, loss of functional residual capacity,
xanthomatendinous and tuberous xanthomas along with corneal
ventilation-perfusion mismatch, severe hypoxemia and lung
arcus.Lipid profile was suggestive of FH.
injury.Surfactant deficiency can be predicted with simple, cheap
shake test method. The aim of this study was to find surfactant Discussion: FH or Frederickson’s type IIa hyperlipoproteinemia
deficiency by using single step gastric aspirate shake test. is an AD disorder caused by>900 mutations in the LDL receptor
gene on chromosome 19, leading to lack of functional receptors
Method: This is an observational study conducted on 79 preterm
for LDL on the cell surface which results into decreased uptake
neonates (28-34 weeks). Gastric aspirate was aspirated within
of LDL into cells from liver, blood, resulting into increased serum
one hour of birth before firstfeed. Shake test was performed by
LDL Cholesterol. There is lack of inhibition of intracellular
taking 0.5ml of normal saline and 1.0ml of 95% ethyl alcohol
cholesterol synthesis.Patients present with multiple types of
test tube, 0.5ml of gastric aspirate was added and vigorously
xanthomata, tuberous, sub periosteal, tendon, elevated plaques
shaken for 15 seconds and allowed to stand for 15 minutes. The
and the rare but characteristic inter-triginous in first decade of life.
surface was inspected for quantum of froth or bubbles and said
to be negative when bubbles cover 1/3rd or less of liquid surface, Conclusion: The diagnosis of FH is important for the patient as
intermediate testif 1/3rd to 2/3rd and positive if 2/3rd or more well as family members for genetic counselling and screening of
suggesting full pulmonary maturity. first degree relatives and extended family members.
Results: Out of 79 preterm neonates (44 males and 35 female), 36
were born at POG 30-34 weeks, 30 at 30-32 weeks and 13 at 28- Disease Spectrum and Outcomes in
30 weeks. 9 had negative test while 12 and 58 had intermediate Paediatric Patients requiring Mechanical
and positive results respectively. All neonates with negative
shake test developed RDS while 11 out of 12 neonates with
Ventilation at Kenyatta National Hospital
intermediate test developed RDS and 1 neonate with positive Saini N*, Kumar R, Wamalwa D, Mungai L, Reel B
shake test also developed RDS. This shake test has sensitivity of Department of Paediatrics and Child Health, University of
95.2%, specificity of 98.26%, PPV and NPV of 95.24%, 98.28% Nairobi, Kenya
respectively. *Email: nupursaini27@gmail.com
Conclusion: A large proportion of infants with negative single Background: The burden of critical illness in developing
step gastric aspirate shake test develop RDS. The test is worth countries is inadequately defined and intensive care resources
performing as an aid tomanagement and diagnosis of RDS. are limited. We sought to describe the nature of illnesses for
Handa S.1, Wasim S.*, Pandita N.*, Pediatrics, Pramukh Swami Medical College,
Kalra B.P.*, Chandar V.* Karamsad-388325(GUJ)
2 year Pediatric Resident, *Department of Pediatrics,
1 nd
M: 9879531972; Email: krutikart@chrutarhealth.org
2
Drug Monitoring in Pediatric Patients Background: Cerebral edema is the leading cause of morbidity
with Serious Infections and mortality in DKA. While clinical cerebral edema occurs in
Dimpi Mhatre, Rekha Solomon*, Soonu Udani 1-2% children with DKA in west, limited Indian studies suggest
PD Hinduja Hospital,Mumbai much higher figures. Identification of risk factors for the same
*Email: rekhasolomon1@gmail.com would help in timely identification and treatment of the condition.
Objective: To evaluate the prevalence and risk factors for
cerebral edema in children with DKA.
Introduction: The recommended dosing to achieve therapeutic Design: Ongoing prospective observational study (January
trough concentrations of vancomycinis15-20 mg/kg. 2014- August 31 2015).
Aim: To investigate if current recommended dosing of Results: Fifty-one children (30 boys, 9 months-18 years) presented
Vancomycinachieves target trough concentrations (TTC) in with DKA (32 first episode, 19 recurrent) over the study period.
pediatric patients with suspected/ known MRSA infections. Fifteen children developed cerebral edema (10 on admission) with
Methods: Fifty-one trough levels in 45 children aged 1 month to ten requiring mechanical ventilation. Cerebral edema was present
18 years, receivingVancomycin therapy in doses of 40 to 50 mg/ at presentation in 10, developed within 12 hours in 5 and after 12
kg/day (group A) or 55 to 65 mg/kg/day (group B)for suspected hours in 1. All children had normal outcome with the exception of
(febrile neutropenic or CRBSI) or proven serious infections were a six-year-old girl with very severe metabolic acidosis and cerebral
studied retrospectively.Chi-square/ Mann-Whitney Utest used edema at onset died at 12 hours of treatment. Risk factors of
for differences in characteristics between patients that achieved cerebral edema included fluid/insulin treatment prior to admission
TTC (≥15 μg/ml)and those that did not (<15 μg/ml). (46.6% versus 8.5%), fresh diagnosis of diabetes (86.5% versus
63.3%) and severity of metabolic acidosis (base excess -23.9 ± 3.8
Results: Most patients (91.2%) received empiric therapy,only
versus -18.8 ± 6.7, p 0.02).
4(8.8%) had positive MRSA cultures. With 12/51(23.5%)
achieving TTC, dose levels did not correlate with trough levels Conclusion: Cerebral edema is alarmingly common in Indian
(Spearman’s r=-0.11, p=0.43). There were 21(46.6%) and children with DKA with over half having it at the time of
24(53.3%) patients in group A and group B, respectively. While diagnosis. Careful monitoring and management is essential
8(33%) in group B achieved TTC, only 2(9.4%) in group Ahad for children with fresh diagnosis of diabetes, severe metabolic
achieved TTC. Patients that achieved TTC were more likely to acidosis and those who have received treatment before admission.
be younger (p=0.07, effect size=0.32) and belong to group B Key Words: DKA, children, cerebral edema.
(p=0.07, effect size=0.28) than those that did not achieve TTC.
Achievement of TTC did not affect clinical outcomes. None of
our patients showed nephrotoxicity as a result of vancomycin Serum Lactate as Marker of Severe
therapy. Dengue
Conclusion: Current recommended vancomycindosing Sarika Gupta
regimensdo not achieve recommended target trough levels. Assistant Professor, Department of Pediatrics, KGMU,
Increase in dosing to 60 mg/kg/day failed to achieve TTC ≥15 Lucknow, India
μg/ml in most patients. Alternative treatment practices such as Email: sgguptasarika@gmail.com
use of loading dose or continuous infusion can be investigated
further. Background: Early diagnosis of severe dengue during febrile
stage is essential for adjusting appropriate management. As
Type of study: Retrospective observational severe dengue patients develop shock and experience hepatic
injury also, it means that serum lactate may be elevated in
such patients.The study was done to determine the association
between serum lactate and severe dengue.
Methods: This was a hospital based reterospective study
Psychosocial Needs in a Pediatric Critical Background: Acute respiratory infections (ARI) are one of
the major causes of morbidity and mortality in young children.
Care Unit - A comparative study of The epidemiology of acute respiratory infection is constantly
careseekers’ and caregivers’ perspectives changing in which both viral and bacterial causal agents play
from a developing country various roles. This study was done to identify viruses associated
with primary acute respiratory tract infection among children
Reshma A, Sasidaran K*, Niranjan V, Ayyammal P,
less than 5 years admitted to PICU and requiring respiratory
Thangavelu S, Nedunchezhian K support or oxygen therapy.
Mehta hospital, Chennai
*M: +91 9940587408; sasidarpgi@gmail.com Methods: It is a prospective observational study. We enrolled
children aged 1 to 60 months admitted to PICU with primary
Background: Children in critical care units put an immense acute respiratory infection requiring minimum 12 hours of
psychological burden on the family members of the child. oxygen therapy between August 2014 and March 2015. Throat
Assessing the psychosocial needs of family members becomes swabs were taken for all children enrolled and viruses isolated
of paramount importance in this regard. This study was by RtPCR technique. We also performed a comparison between
designed to explore the needs of family member of children viral isolate positive and negative children with regards to
unexpectedly admitted to an Intensive Care Unit and rank the surrogate diagnostic markers and outcome measures
needs and compare with the perspectives of doctors, nurses and
Results and Discussion: Of 70 children who fulfilled the
administrators.
enrolment criteria, 35(50%) were found to have viral etiology.
Methods: This is an exploratory comparative study done Rhino virus was found to be the most common isolated in15
prospectively using a modified version of the Critical Care (42.85%) children followed by RSV accounting for 14(40 %)
Family Needs Inventory (CCFNI) to measure, rank and compare children. Of 22 children requiring advanced invasive ventilator
the needs and the Needs Met Inventory (NMI) to assess the level support, 9 children were found to have respiratory virus isolate.
of satisfaction of the needs. The study was done in a private Commonly used surrogate diagnostic markers like CRP, ALC,
sector pediatric ICU in south India. Responses of 35 consecutive and ANC were found to be not significantly different between
family members, 30 Pediatric acute care Nurses, 30 pediatricians the groups.
involved in intensive care and 30 administrators responsible for
Conclusion: Viral pneumonia is one of the common causes of
ICU decisions were recorded.
ARI in children mandating intensive care unit admission and
Results: The responses were ranked by means and analysed for viral pneumonia need not always be mild and self-limiting in
variance by univariate analysis and the responses were compared immunocompetent. In our observation, Human rhino virus and
between the care seekers’ and care providers. The needs ranked RSV were the two most common viral isolates and H1N1 was
highest by domain were “Assurance” for families, doctors and associated with disease severity.
Conclusions: In a first such study from india, we demonstrate Method: Three infants with propionic acidemia PA (n=1),
the feasibility of implementing a pediatric equivalent of Medical citrullinemia (n=1) and multiple carboxylase deficiency (n=1) who
Emergency Team(MET), that has the potential for reducing the were given breast milk and prospectively followed were included.
mortality and morbidity in children admitted to a tertiary hospital. Results
Case 1: A 13 month old boy diagnosed to have propionic
Proteus Syndrome With Epilepsy: A Rare academia on 20 day of life (dol), was continued on BF after
Presentation the acute management of the crisis. He is on BF till date and
supplemented on special formula. He had 2 episodes of acute
Pallavi1 S. Sitaraman1, Manisha Goyal2 crisis so far and developmentally normal.
¹Department of Pediatrics, SMS Medical College, Jaipur,
²Clinical Geneticist, Jaipur Case 2: A 9 month old boy diagnosed to have multiple
1
Email: psachdeva1988@gmail.com carboxylase on y 7 dol, presented antenatally with cyst, was
continued on BF after discharge. He was on exclusive BF till 6
Background: Proteus syndrome (PS) is an overgrowth syndrome months of age and developmentally normal.
characterized by segmental overgrowth, vascular malformations, Case 3: A 7 month old girl diagnosed to have citrullinemia on
nevi, lipoma and hyperpigmentation. The exact cause and 1 dol, in view of sibling with IEM, was continued on expressed
embryologic origin of PS is still not known. BM after acute management. She is developmentally normal.
Case presentation: A seven year old boy presented with seizures Conclusion: Breast feeding was successful in all three babies
and overgrowth of right half of the body. He was third born to non- with IEM. Metabolic decompensation should be watched for
consanguineous couple with uneventful antenatal and postnatal